EGFR-TKIs plus chemotherapy demonstrated superior efficacy than EGFR-TKIs alone as first-line setting in advanced NSCLC patients with EGFR mutation and BIM deletion polymorphism
Titel:
EGFR-TKIs plus chemotherapy demonstrated superior efficacy than EGFR-TKIs alone as first-line setting in advanced NSCLC patients with EGFR mutation and BIM deletion polymorphism
Auteur:
Liu, Sangtian He, Yayi Jiang, Tao Ren, Shengxiang Zhou, Fei Zhao, Chao Li, Xuefei Zhang, Jie Su, Chunxia Chen, Xiaoxia Cai, Weijing Gao, Guanghui Li, Wei Wu, Fengying Li, Jiayu Zhao, Jing Hu, Qiong Zhao, Mingchuan Zhou, Caicun Hirsch, Fred R.